Revolution Medicines, Inc. (NASDAQ:RVMDW) Stock Short Interest Jumps 106.3%

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the target of a large growth in short interest during the month of October. As of October 15th, there was short interest totaling 1,578 shares, a growth of 106.3% from the September 30th total of 765 shares. Based on an average daily trading volume, of 19,075 shares, the days-to-cover ratio is currently 0.1 days.

Revolution Medicines Stock Performance

RVMDW traded up $0.17 during midday trading on Friday, reaching $9.81. 5,614 shares of the company’s stock were exchanged, compared to its average volume of 94,843. Revolution Medicines has a 1-year low of $0.34 and a 1-year high of $13.44. The business’s 50-day moving average price is $10.69 and its 200 day moving average price is $6.63.

Revolution Medicines Company Profile

Revolution Medicines, Inc is a clinical-stage biopharmaceutical company focused on developing targeted therapies for patients with cancer. The company’s research is centered on the RAS signaling pathway, which is frequently altered in tumors and has historically been difficult to target with medicines.

Revolution Medicines is developing a pipeline of RAS(ON) inhibitors designed to block active RAS proteins and related signaling. Its investigational programs include daraxonrasib (RMC-6236), an oral, broad-spectrum RAS(ON) inhibitor, as well as mutation-selective candidates such as RMC-9805 for KRAS G12D and RMC-6291 for KRAS G12C.